Abdera Therapeutics Receives FDA Orphan Drug Designation for ABD-147
05 Sep 2024 //
BUSINESSWIRE
Vistagen Earns Mental Health America’s Platinum Bell Seal for Workplace
27 Jun 2024 //
BUSINESSWIRE
Abdera Therapeutics Announces FDA Clearance of IND Application for ABD-147
23 May 2024 //
BUSINESSWIRE
Abdera Therapeutics Expands Management Team and Board of Directors
30 Jan 2024 //
BUSINESSWIRE
Abdera Therapeutics Debuts With $142 Million in Financing to Engineer
20 Apr 2023 //
BUSINESSWIRE
Abdera exits stealth with $142M to develop radiopharmaceuticals
20 Apr 2023 //
FIERCE BIOTECH